Comparative Analysis of Transcriptomic and Proteomic Expression between Two Non-Small Cell Lung Cancer Subtypes

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Non-small cell lung cancer (NSCLC) diagnosis is often late, leading to poor survival.
• Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are distinct NSCLC subtypes requiring targeted therapies.
• Current diagnostic methods for NSCLC subtypes are limited, necessitating advanced tools.

Purpose of the Study:

• To compare transcriptomic and proteomic expression in LUAD and LUSC.
• To identify subtype-specific molecular differences for potential therapeutic targets.
• To inform the development of novel diagnostic biomarkers for NSCLC.

Main Methods:

• Comparative analysis of transcriptomic and proteomic data from 22 NSCLC patients (14 LUAD, 8 LUSC).
• Examination of differential gene and protein expression between NSCLC subtypes.
• Analysis focused on subtype-specific pathways rather than tumor vs. control.

Main Results:

• Differential gene expression in LUSC related to cell differentiation; in LUAD, related to cellular structure and immune response.
• Differential protein expression in LUSC linked to extracellular structure; in LUAD, linked to metabolic processes like glucose metabolism.
• Direct subtype comparison yielded more informative pathway insights than comparisons with non-tumor tissues.

Conclusions:

• Significant molecular distinctions exist between LUAD and LUSC, impacting cell differentiation, structure, immunity, and metabolism.
• These findings support existing knowledge and reveal novel differences crucial for biomarker and therapeutic target discovery.
• Subtype-specific analysis is key to understanding NSCLC heterogeneity and advancing personalized treatment strategies.